Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Christian Quirin
Introduction
Christian Quirin is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biocatalysis, particularly in the reduction of dehydrocholic acid compounds. His work has implications for the production of important pharmaceutical compounds.
Latest Patents
Christian Quirin holds a patent for a "Method for biocatalytic whole cell reduction of dehydrocholic acid compounds, and 7-β-hydroxysteroid dehydrogenase mutants." This invention relates to novel biocatalytic processes that involve the whole cell reduction of dehydrocholic acid (DHCA) compounds. It also includes novel 7β-hydroxy steroid dehydrogenase mutants, the sequences coding for these enzyme mutants, and methods for producing the enzyme mutants. The invention is particularly focused on enzymatic conversions of cholic acid compounds, especially in the production of ursodesoxycholic acid (UDCA). Additionally, it presents improved methods for synthesizing UDCA using recombinant whole cell biocatalysts.
Career Highlights
Christian Quirin is associated with Pharmazell GmbH, where he applies his expertise in biocatalysis. His innovative work has positioned him as a key figure in the development of new biocatalytic methods that enhance pharmaceutical production.
Collaborations
Christian has collaborated with notable colleagues such as Dirk Weuster-Botz and Boqiao Sun. Their combined efforts contribute to advancing research in biocatalysis and its applications in the pharmaceutical industry.
Conclusion
Christian Quirin's contributions to biocatalysis and his innovative patent highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has practical applications in the production of important pharmaceutical compounds.